These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 17342749)

  • 41. Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells.
    Gravina GL; Festuccia C; Angelucci A; Poletti A; Capuano D; Vicentini C; Motta M; Bologna M
    Int J Oncol; 2004 Jul; 25(1):97-104. PubMed ID: 15201994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG
    Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.
    Lee SO; Pinder E; Chun JY; Lou W; Sun M; Gao AC
    Prostate; 2008 Jan; 68(1):85-91. PubMed ID: 18008330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
    Heemers HV; Regan KM; Dehm SM; Tindall DJ
    Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate androgen-regulated gene: a novel potential target for androgen-independent prostate cancer therapy.
    Xu XF; Zhou SW; Zhang X; Ye ZQ; Zhang JH; Ma X; Zheng T; Li HZ
    Asian J Androl; 2006 Jul; 8(4):455-62. PubMed ID: 16763722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells.
    Eder IE; Haag P; Basik M; Mousses S; Bektic J; Bartsch G; Klocker H
    Mol Carcinog; 2003 Aug; 37(4):181-91. PubMed ID: 12891627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
    Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
    J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
    Chen F; Knecht K; Leu C; Rutledge SJ; Scafonas A; Gambone C; Vogel R; Zhang H; Kasparcova V; Bai C; Harada S; Schmidt A; Reszka A; Freedman L
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):247-57. PubMed ID: 15336702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH
    Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells.
    Makkonen H; Kauhanen M; Jääskeläinen T; Palvimo JJ
    Mol Cell Endocrinol; 2011 Jan; 331(1):57-65. PubMed ID: 20728506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
    Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression, regulation and function of the ISGylation system in prostate cancer.
    Kiessling A; Hogrefe C; Erb S; Bobach C; Fuessel S; Wessjohann L; Seliger B
    Oncogene; 2009 Jul; 28(28):2606-20. PubMed ID: 19430494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J; Xie B; Capodice JL; Katz AE
    Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-4 in patients with prostate cancer.
    Takeshi U; Sadar MD; Suzuki H; Akakura K; Sakamoto S; Shimbo M; Suyama T; Imamoto T; Komiya A; Yukio N; Ichikawa T
    Anticancer Res; 2005; 25(6C):4595-8. PubMed ID: 16334148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgen receptor regulates CD168 expression and signaling in prostate cancer.
    Lin SL; Chang D; Chiang A; Ying SY
    Carcinogenesis; 2008 Feb; 29(2):282-90. PubMed ID: 18174258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
    Shiota M; Yokomizo A; Naito S
    Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PC-3 cells with enhanced androgen receptor signaling: a model for clonal selection in prostate cancer.
    Buchanan G; Craft PS; Yang M; Cheong A; Prescott J; Jia L; Coetzee GA; Tilley WD
    Prostate; 2004 Sep; 60(4):352-66. PubMed ID: 15264248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines.
    Diallo JS; Péant B; Lessard L; Delvoye N; Le Page C; Mes-Masson AM; Saad F
    Prostate; 2006 Sep; 66(12):1245-56. PubMed ID: 16705740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.